Detection of early behavioral markers of Huntington's disease in R6/2 mice employing an automated social home cage

Behavioural Brain Research

Volumn 203, Issue 2, 2009, Pages 188-199

  Rudenko, Olga ^a   Tkach, Vadim ^a   Berezin, Vladimir ^a   Bock, Elisabeth ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Automated behavior analysis; Huntington's disease; IntelliCage; Learning; R6 2 mice

Indexed keywords

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL HOUSING; ANIMAL MODEL; ARTICLE; BEHAVIOR DISORDER; CIRCADIAN RHYTHM; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE MARKER; DRINKING BEHAVIOR; EXPLORATORY BEHAVIOR; HUNTINGTON CHOREA; LEARNING; MENTAL TASK; MOUSE; NONHUMAN; PRIORITY JOURNAL; SLEEP DISORDER; SPATIAL ORIENTATION; TRANSGENIC MOUSE;

ANIMALS; AVOIDANCE LEARNING; BODY WEIGHT; CIRCADIAN RHYTHM; DISEASE MODELS, ANIMAL; DRINKING BEHAVIOR; EXPLORATORY BEHAVIOR; FEMALE; HUNTINGTON DISEASE; MICE; MICE, TRANSGENIC; MOTOR ACTIVITY; PHENOTYPE; ROTAROD PERFORMANCE TEST; SPATIAL BEHAVIOR;

EID: 67649635619     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2009.04.034     Document Type: Article

References (55)

1. Aron A.R., Watkins L., Sahakian B.J., Monsell S., Barker R.A., and Robbins T.W. Task-set switching deficits in early-stage Huntington's disease: implications for basal ganglia function. J Cogn Neurosci 15 (2003) 629-642
2. Backman L., Robins-Wahlin T.B., Lundin A., Ginovart N., and Farde L. Cognitive deficits in Huntington's disease are predicted by dopaminergic PET markers and brain volumes. Brain 120 Pt 12 (1997) 2207-2217
3. Bolivar V.J., Manley K., and Messer A. Exploratory activity and fear conditioning abnormalities develop early in R6/2 Huntington's disease transgenic mice. Behav Neurosci 117 (2003) 1233-1242
4. Borrell-Pages M., Zala D., Humbert S., and Saudou F. Huntington's disease: from huntingtin function and dysfunction to therapeutic strategies. Cell Mol Life Sci 63 (2006) 2642-2660
5. Carter R.J., Lione L.A., Humby T., Mangiarini L., Mahal A., Bates G.P., et al. Characterization of progressive motor deficits in mice transgenic for the human Huntington's disease mutation. J Neurosci 19 (1999) 3248-3257
6. Cha J.H. Transcriptional signatures in Huntington's disease. Prog Neurobiol 83 (2007) 228-248
7. Chopra V., Fox J.H., Lieberman G., Dorsey K., Matson W., Waldmeier P., et al. A small-molecule therapeutic lead for Huntington's disease: preclinical pharmacology and efficacy of C2-8 in the R6/2 transgenic mouse. Proc Natl Acad Sci USA 104 (2007) 16685-16689
8. Domenici M.R., Scattoni M.L., Martire A., Lastoria G., Potenza R.L., Borioni A., et al. Behavioral and electrophysiological effects of the adenosine A2A receptor antagonist SCH 58261 in R6/2 Huntington's disease mice. Neurobiol Dis 28 (2007) 197-205
9. Dorner J.L., Miller B.R., Barton S.J., Brock T.J., and Rebec G.V. Sex differences in behavior and striatal ascorbate release in the 140 CAG knock-in mouse model of Huntington's disease. Behav Brain Res 178 (2007) 90-97
10. Ferrante R.J., Andreassen O.A., Dedeoglu A., Ferrante K.L., Jenkins B.G., Hersch S.M., et al. Therapeutic effects of coenzyme Q10 and remacemide in transgenic mouse models of Huntington's disease. J Neurosci 22 (2002) 1592-1599
11. Gabrieli J.D., Stebbins G.T., Singh J., Willingham D.B., and Goetz C.G. Intact mirror-tracing and impaired rotary-pursuit skill learning in patients with Huntington's disease: evidence for dissociable memory systems in skill learning. Neuropsychology 11 (1997) 272-281
12. Galsworthy M.J., Amrein I., Kuptsov P.A., Poletaeva I.I., Zinn P., Rau A., et al. A comparison of wild-caught wood mice and bank voles in the IntelliCage: assessing exploration, daily activity patterns and place learning paradigms. Behav Brain Res 157 (2005) 211-217
13. Hamakawa S., Koda C., Umeno H., Yoshida Y., Nakashima T., Asaoka K., et al. Oropharyngeal dysphagia in a case of Huntington's disease. Auris Nasus Larynx 31 (2004) 171-176
14. Heindel W.C., Butters N., and Salmon D.P. Impaired learning of a motor skill in patients with Huntington's disease. Behav Neurosci 102 (1988) 141-147
15. Hersch S.M., and Rosas H.D. Neuroprotection for Huntington's disease: ready, set, slow. Neurotherapeutics 5 (2008) 226-236
16. Hickey M.A., Gallant K., Gross G.G., Levine M.S., and Chesselet M.F. Early behavioral deficits in R6/2 mice suitable for use in preclinical drug testing. Neurobiol Dis 20 (2005) 1-11
17. Hockly E., Woodman B., Mahal A., Lewis C.M., and Bates G. Standardization and statistical approaches to therapeutic trials in the R6/2 mouse. Brain Res Bull 61 (2003) 469-479
18. The Huntington's Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 72 (1993) 971-983
19. Hurlbert M.S., Zhou W., Wasmeier C., Kaddis F.G., Hutton J.C., and Freed C.R. Mice transgenic for an expanded CAG repeat in the Huntington's disease gene develop diabetes. Diabetes 48 (1999) 649-651
20. Imarisio S., Carmichael J., Korolchuk V., Chen C.W., Saiki S., Rose C., et al. Huntington's disease: from pathology and genetics to potential therapies. Biochem J 412 (2008) 191-209
21. Kazantsev A.G., and Hersch S.M. Drug targeting of dysregulated transcription in Huntington's disease. Prog Neurobiol 83 (2007) 249-259
22. Knapska E., Walasek G., Nikolaev E., Neuhäusser-Wespy F., Lipp H.P., Kaczmarek L., et al. Differential involvement of the central amygdala in appetitive versus aversive learning. Learn Mem 13 (2006) 192-200
23. Knopman D., and Nissen M.J. Procedural learning is impaired in Huntington's disease: evidence from the serial reaction time task. Neuropsychologia 29 (1991) 245-254
24. Kotliarova S., Jana N.R., Sakamoto N., Kurosawa M., Miyazaki H., Nekooki M., et al. Decreased expression of hypothalamic neuropeptides in Huntington disease transgenic mice with expanded polyglutamine-EGFP fluorescent aggregates. J Neurochem 93 (2005) 641-653
25. Lange K.W., Sahakian B.J., Quinn N.P., Marsden C.D., and Robbins T.W. Comparison of executive and visuospatial memory function in Huntington's disease and dementia of Alzheimer type matched for degree of dementia. J Neurol Neurosurg Psychiatry 58 (1995) 598-606
26. Lawrence A.D., Sahakian B.J., Rogers R.D., Hodge J.R., and Robbins T.W. Discrimination, reversal, and shift learning in Huntington's disease: mechanisms of impaired response selection. Neuropsychologia 37 (1999) 1359-1374
27. Lawrence A.D., Watkins L.H., Sahakian B.J., Hodges J.R., and Robbins T.W. Visual object and visuospatial cognition in Huntington's disease: implications for information processing in corticostriatal circuits. Brain 123 Pt 7 (2000) 1349-1364
28. Leussis M.P., and Bolivar V.J. Habituation in rodents: a review of behavior, neurobiology, and genetics. Neurosci Biobehav Rev 30 (2006) 1045-1064
29. Lione L.A., Carter R.J., Hunt M.J., Bates G.P., Morton A.J., and Dunnett S.B. Selective discrimination learning impairments in mice expressing the human Huntington's disease mutation. J Neurosci 19 (1999) 10428-10437
30. Lipp HP, Litvin O, Galsworthy M, Vyssotski DL, Vyssotski AL, Zinn P, et al. Automated behavioral analysis of mice using INTELLICAGE: inter-laboratory comparisons and validation with exploratory behavior and spatial learning. In: Noldus LPJJ, Grieco F, Loijens LWS, Zimmerman HP, editors. Proceedings of measuring behavior 2005: 5th international conference on methods and techniques in behavioral research. Wageningen, The Netherlands: Noldus Information Technology; 2005. p. 66-9.
31. Luesse H.G., Schiefer J., Spruenken A., Puls C., Block F., and Kosinski C.M. Evaluation of R6/2 HD transgenic mice for therapeutic studies in Huntington's disease: behavioral testing and impact of diabetes mellitus. Behav Brain Res 126 (2001) 185-195
32. Mangiarini L., Sathasivam K., Seller M., Cozens B., Harper A., Hetherington C., et al. Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 87 (1996) 493-506
33. Miller B.R., Dorner J.L., Shou M., Sari Y., Barton S.J., Sengelaub D.R., et al. Up-regulation of GLT1 expression increases glutamate uptake and attenuates the Huntington's disease phenotype in the R6/2 mouse. Neuroscience 153 (2008) 329-337
34. Morris M. Dementia and cognitive changes in Huntington's disease. Adv Neurol 65 (1995) 187-200
35. Morton A.J., Hunt M.J., Hodges A.K., Lewis P.D., Redfern A.J., Dunnett S.B., et al. A combination drug therapy improves cognition and reverses gene expression changes in a mouse model of Huntington's disease. Eur J Neurosci 21 (2005) 855-870
36. Morton A.J., Skillings E., Bussey T.J., and Saksida L.M. Measuring cognitive deficits in disabled mice using an automated interactive touchscreen system. Nat Meth 3 (2006) 767
37. Murphy K.P., Carter R.J., Lione L.A., Mangiarini L., Mahal A., Bates G.P., et al. Abnormal synaptic plasticity and impaired spatial cognition in mice transgenic for exon 1 of the human Huntington's disease mutation. J Neurosci 20 (2000) 5115-5123
38. Onishchenko N., Tamm C., Vahter M., Hokfelt T., Johnson J.A., Johnson D.A., et al. Developmental exposure to methylmercury alters learning and induces depression-like behavior in male mice. Toxicol Sci 97 (2007) 428-437
39. Oscar-Berman M., Zola-Morgan S.M., Oberg R.G., and Bonner R.T. Comparative neuropsychology and Korsakoff's syndrome. III. Delayed response, delayed alternation and DRL performance. Neuropsychologia 20 (1982) 187-202
40. Ramaswamy S., McBride J.L., and Kordower J.H. Animal models of Huntington's disease. ILAR J 48 (2007) 356-373
41. Reiner A., Dragatsis I., Zeitlin S., and Goldowitz D. Wild-type huntingtin plays a role in brain development and neuronal survival. Mol Neurobiol 28 (2003) 259-276
42. Rigamonti D., Sipione S., Goffredo D., Zuccato C., Fossale E., and Cattaneo E. Huntingtin's neuroprotective activity occurs via inhibition of procaspase-9 processing. J Biol Chem 276 (2001) 14545-14548
43. Rohrer D., Salmon D.P., Wixted J.T., and Paulsen J.S. The disparate effects of Alzheimer's disease and Huntington's disease on semantic memory. Neuropsychology 13 (1999) 381-388
44. Sapp E., Schwarz C., Chase K., Bhide P.G., Young A.B., Penney J., et al. Huntingtin localization in brains of normal and Huntington's disease patients. Ann Neurol 42 (1997) 604-612
45. Schmidtke K., Manner H., Kaufmann R., and Schmolck H. Cognitive procedural learning in patients with fronto-striatal lesions. Learn Mem 9 (2002) 419-429
46. Snowden J.S., Craufurd D., Thompson J., and Neary D. Psychomotor, executive, and memory function in preclinical Huntington's disease. J Clin Exp Neuropsychol 24 (2002) 133-145
47. Steele A.D., Jackson W.S., King O.D., and Lindquist S. The power of automated high-resolution behavior analysis revealed by its application to mouse models of Huntington's and prion diseases. Proc Natl Acad Sci USA 104 (2007) 1983-1988
48. Trueman R.C., Brooks S.P., Jones L., and Dunnett S.B. The operant serial implicit learning task reveals early onset motor learning deficits in the Hdh knock-in mouse model of Huntington's disease. Eur J Neurosci 25 (2007) 551-558
49. van der Burg J.M., Bacos K., Wood N.I., Lindqvist A., Wierup N., Woodman B., et al. Increased metabolism in the R6/2 mouse model of Huntington's disease. Neurobiol Dis 29 (2008) 41-51
50. Watkins L.H., Rogers R.D., Lawrence A.D., Sahakian B.J., Rosser A.E., and Robbins T.W. Impaired planning but intact decision making in early Huntington's disease: implications for specific fronto-striatal pathology. Neuropsychologia 38 (2000) 1112-1125
51. Welker W.I. "Free" versus "forced" exploration of a novel situation by rats. Psychol Rep 3 (1957) 95-108
52. White J.K., Auerbach W., Duyao M.P., Vonsattel J.P., Gusella J.F., Joyner A.L., et al. Huntingtin is required for neurogenesis and is not impaired by the Huntington's disease CAG expansion. Nat Genet 17 (1997) 404-410
53. Wilson R.S., Como P.G., Garron D.C., Klawans H.L., Barr A., and Klawans D. Memory failure in Huntington's disease. J Clin Exp Neuropsychol 9 (1987) 147-154
54. Wood N.I., Goodman A.O., van der Burg J.M., Gazeau V., Brundin P., Bjorkqvist M., et al. Increased thirst and drinking in Huntington's disease and the R6/2 mouse. Brain Res Bull 76 (2008) 70-79
55. Zeitlin S., Liu J.P., Chapman D.L., Papaioannou V.E., and Efstratiadis A. Increased apoptosis and early embryonic lethality in mice nullizygous for the Huntington's disease gene homologue. Nat Genet 11 (1995) 155-163